IEFM
IQ EQ Fund Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.61M | Buy |
911,085
+523,848
| +135% | +$2.65M | 0.41% | 78 |
|
|
2025
Q1 | $2.05M | Buy |
387,237
+186,767
| +93% | +$988K | 0.24% | 115 |
|
|
2024
Q4 | $1.36M | Buy |
200,470
+118,118
| +143% | +$798K | 0.16% | 148 |
|
|
2024
Q3 | $543K | Buy |
82,352
+42,101
| +105% | +$277K | 0.06% | 253 |
|
|
2024
Q2 | $302K | Buy |
+40,251
| New | +$302K | 0.03% | 274 |
|